QualityStocksNewsBreaks Archives - Page 565 of 1423

FridaySep 24, 2021 1:28 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Garners Attention as ‘Emerging Leader in the Psychedelic Therapeutics Space’

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently released its Q1 2021 operational and financial report for the period ended June 30, 2021. The biotech company hit several milestones, including becoming the first psychedelic company to list on the NYSE American LLC stock exchange and raising more than CA$120 million. In addition, Cybin has started the next phase of its digital therapeutics platform, signed an exclusive R&D collaboration agreement with TMS NeuroHealth Centers Inc to establish Mental Health Centers of Excellence, as well as commenced scaling up its…

FridaySep 24, 2021 12:25 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Release FY 2021 Financial Report and Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has released its financial results and corporate update for FY 2021. In addition, the company announced a conference call and webcast, in which company leadership will discuss the report. Interested parties can access a replay of the webcast for 90 days. Corporate highlights of the report include the definitive agreement the company entered to acquire BayMedica Inc., a private company specializing in the manufacture and commercialization of rare cannabinoids; the announcement that INM’s IntegraSyn(TM) cannabinoid manufacturing approach had achieved a level of 2g/L cannabinoid yield,…

ThursdaySep 23, 2021 2:23 pm

QualityStocksNewsBreaks – Brain Scientific Inc.’s (BRSF) Proprietary Brain Diagnostics Devices Positioned to Profoundly Shift EEG Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is leveraging artificial intelligence (“AI”) and machine learning (“ML”) to improve diagnostic capability using a database of biomarkers that collect data on both normal and abnormal brain information. Brain Scientific’s use of AI and ML is part of its overall strategy to penetrate the rapidly growing electroencephalogram (“EEG”) market. The strategy includes developing its patented FDA-cleared NeuroCap(TM) and NeuroEEG(TM) devices. NeuroCap is a disposable pre-gelled EEG headset with 22 electrodes and 19 active EEG channels that can be used to record EEGs in nearly any setting.…

ThursdaySep 23, 2021 2:03 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Committed to Increasing Market Reach, Product Line, Quality of Offerings

FingerMotion (OTCQX: FNGR) has always endeavored to deliver the next generation of data-driven technology solutions that cut across its current product line and service offerings. Even so, the company, which currently provides solutions to the Chinese market, is seeking expansion. “Going forward, it seeks to expand into other regions and further introduce other innovative offerings, mainly in collaboration with other tech companies in specific industries. So far, associations with Happy Life Insurance and Xunlian Tanxia Technology show FNGR’s commitment to this path and highlight its future,” reads a recent article. “This company is committed to growing its user base organically,…

ThursdaySep 23, 2021 1:43 pm

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Witnesses Impressive First Half of 2021

AmpliTech Group (NASDAQ: AMPG) recently announced financial results for the first six months of the 2021 fiscal year, along with Q2 2021 results. “The first six months of 2021 were significant for AmpliTech,” reads a recent article. “For starters, the company completed its financial recapitalization and Nasdaq uplisting. This move allowed it to raise working capital of $29.8 million as of June 30. This capital would go into product development, sales and marketing infrastructure investments while also offering the financial strength needed to engage with global customer prospects that were previously out of the company’s reach.” The company was also…

ThursdaySep 23, 2021 1:30 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Unveils New A88CBD(TM) Functional Waters

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has launched a new line of A88CBD(TM) functional waters powered by Vessl(R). The new natural CBD functional waters have six options: Relax, Refresh, Rest, Reenergize, Relief and Resistance. The new offerings feature the patented Vessl closure technology, which is designed to provide fresher ingredients and flavor. The new brand, which represents a strategic move into the functional beverages space for WTER, will be sold under the company’s A88 Infused Products Division Inc. With the Vessl closure technology, the CBD and other active, functional ingredients are stored in a…

ThursdaySep 23, 2021 11:59 am

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Technologies Inc. Announce Strategic Partnership for Upcoming Mullen EV Launch

Mullen Technologies, an emerging electric vehicle manufacturer, which previously announced a definitive agreement to merge with Net Element (NASDAQ: NETE), today announced its entry into a letter of intent (“LOI”) with hofer powertrain GmbH. Under the collaboration, Mullen and hofer powertrain will partner in the development and manufacturing of electric drive systems and components for Mullen’s EV lineup, along with a high-performance powertrain for the DragonFLY, to deliver unprecedented performance in the market. hofer powertrain is a renowned Tier 1 engineering service provider and system supplier specialized in efficient powertrain solutions. As an established and independent partner of the automotive industry…

ThursdaySep 23, 2021 11:04 am

QualityStocksNewsBreaks – Tingo Inc. (IWBB) Names New Board Cochairs

Tingo (OTC: IWBB) has strengthened its already strong board of directors with the appointment of two new cochairs: John J. Brown and Christophe Francois Charlier.The two men bring impressive global experience to their new roles and represent a strategic move for the company as it works to list its shares on a national securities exchange such as the New York Stock Exchange. Named as independent cochair, Brown has served as managing partner of Sands Point Consulting LLC as well as an advisor to an array of entrepreneurs, founders and senior corporate leaders to assist and support in developing new business strategies…

ThursdaySep 23, 2021 10:31 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Reiterates Engaging Lineup for Its Two-Day Immersive Edutainment Experience – Meet Delic

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today reiterated the full lineup of thought leaders, entrepreneurs, medical experts and entertainers taking part at its two-day premier Meet Delic psychedelics event. The experiential event will feature dancers, music, 3D mapping, new technologies and research, thought-provoking presentations and the world’s largest psychedelic business expo. The update includes a complete list of innovators slated to keynote, serve on panels and entertain for the event taking place from Nov. 6-7, 2021, at AREA15, an immersive and experiential venue in Las Vegas. To view the full press release, visit https://ibn.fm/x4ZZn About Delic…

ThursdaySep 23, 2021 9:54 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Forms Medical Consortium to Advance OSA Technology

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced the official formation of the Vivos Medical Consortium. According to the update, this physician working group, led by Drs. Clete Kushida of Stanford University and Cecilia Wu of the University of Alberta, will collaborate to advance Vivos’ OSA technology capabilities. “Every specialty in medicine deals with the negative impact of obstructive sleep apnea in some way, with the end stage of untreated sleep apnea including diminished quality of life,…

Site Search

Company Search

Category: QualityStocksNewsBreaks